Enovis Corp. (ENOV)
25.31
-0.39
(-1.52%)
USD |
NYSE |
Mar 03, 16:00
25.31
0.00 (0.00%)
After-Hours: 20:00
Enovis EPS Diluted (Quarterly) : -9.074 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.0219 |
| Twist Bioscience Corp. | -0.4995 |
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -518.80M |
| Revenue (Quarterly) | 575.76M |
| Total Expenses (Quarterly) | 1.095B |
| Gross Profit Margin (Quarterly) | 51.58% |
| Profit Margin (Quarterly) | -90.11% |
| Earnings Yield | -81.76% |
| Operating Earnings Yield | 0.07% |
| Normalized Earnings Yield | -27.06 |